XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Mar. 27, 2021
Mar. 28, 2020
Mar. 30, 2019
Cash flows from operating activities:      
Net income (loss) $ (121.1) $ 384.3 $ 430.9
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization expense 247.6 269.5 281.3
Deferred income tax expense (benefit) 35.6 (168.8) 8.5
Loss on sale of property 0.0 0.0 11.6
Non-cash stock-based compensation expense 72.7 100.6 88.6
Non-cash impairment of assets, including equity method investment 96.0 38.7 25.8
Bad debt expense (benefit) (27.6) 58.7 0.4
Other non-cash charges (benefits) 1.8 (2.3) 6.5
Changes in operating assets and liabilities:      
Accounts receivable (143.0) 57.6 10.1
Inventories 3.7 72.3 (83.6)
Prepaid expenses and other current assets 5.2 58.2 (40.5)
Accounts payable and accrued liabilities 296.8 (64.3) (4.7)
Income tax receivables and payables (37.8) (42.5) 29.7
Deferred income (3.2) 0.0 (16.5)
Other balance sheet changes (45.8) (7.4) 35.7
Net cash provided by operating activities 380.9 754.6 783.8
Cash flows from investing activities:      
Capital expenditures (107.8) (270.3) (197.7)
Purchases of investments (704.6) (1,289.7) (3,030.8)
Proceeds from sales and maturities of investments 1,007.2 2,240.4 2,357.5
Proceeds from sale of property 0.0 20.8 20.0
Settlement of net investment hedges 3.7 0.0 (23.8)
Other investing activities (3.5) 0.9 (4.5)
Net cash provided by (used in) investing activities 195.0 702.1 (879.3)
Cash flows from financing activities:      
Proceeds from credit facility borrowings 0.0 475.0 0.0
Repayments of credit facility borrowings (475.0) 0.0 (9.9)
Proceeds from the issuance of long-term debt 1,241.9 0.0 398.1
Repayments of long-term debt (300.0) 0.0 (300.0)
Payments of finance lease obligations (13.9) (13.6) (19.6)
Payments of dividends (49.8) (203.9) (190.7)
Repurchases of common stock, including shares surrendered for tax withholdings (37.7) (694.8) (502.6)
Proceeds from exercise of stock options 0.0 0.0 21.8
Other financing activities (8.7) (0.9) (2.8)
Net cash provided by (used in) financing activities 356.8 (438.2) (605.7)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 25.5 (15.2) (27.8)
Net increase (decrease) in cash, cash equivalents, and restricted cash 958.2 1,003.3 (729.0)
Cash, cash equivalents, and restricted cash at beginning of period 1,629.8 626.5 1,355.5
Cash, cash equivalents, and restricted cash at end of period $ 2,588.0 $ 1,629.8 $ 626.5